2010
DOI: 10.1111/j.1753-4887.2010.00272.x
|View full text |Cite
|
Sign up to set email alerts
|

Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides

Abstract: The objectives of this review were to determine whether the long-chain omega-3 fatty acids eicosapentaenoic acid and/or docosahexaenoic acid dose-dependently reduce fasting serum triglycerides (TG) and, if so, to create a mathematical model that may be used to predict potential percent reductions in fasting serum TG levels at the recommended intakes of 200-500 mg/day. The assessment included 15 randomized controlled trials that met pre-defined inclusion and exclusion criteria. Across these 15 studies, the dose… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
47
0
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(49 citation statements)
references
References 39 publications
0
47
0
2
Order By: Relevance
“…211 ). The TAG-lowering effect of LC n-3 PUFA has been well demonstrated, however, the magnitude of the effect varies depending on the dose of supplementation 212,213 . At present, n-3 PUFA ethyl esters are registered for treatment of dyslipidemia in several countries (e.g.…”
mentioning
confidence: 99%
“…211 ). The TAG-lowering effect of LC n-3 PUFA has been well demonstrated, however, the magnitude of the effect varies depending on the dose of supplementation 212,213 . At present, n-3 PUFA ethyl esters are registered for treatment of dyslipidemia in several countries (e.g.…”
mentioning
confidence: 99%
“…65 These effects are primarily seen with prescription fish oils, which contain approximately 465 mg of eicosapentaenoic acid and 375 mg of docosahexaenoic acid. Over the counter preparations have variable quantities of eicosapentaenoic acid and docosahexaenoic acid resulting in variable TG-lowering effects.…”
Section: Drug Treatmentmentioning
confidence: 99%
“…Segundo Musa-Veloso et al [22] , comitês internacionais recomendam a ingestão de 200-500 mg/dia de n-3 PUFA para populações saudáveis. Os autores apontam que tais doses estão associadas a reduções nas concentrações de triglicérides variando de -3,1% (IC95%: -5,9 a -0,31%) a -7,2% (IC95%:-11,6 a -2.5%).…”
Section: Peixeunclassified